Lonza Group Ltd (LZAGY)
58.09
+0.17
(+0.29%)
USD |
OTCM |
May 17, 16:00
Lonza Group Price: 58.09 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 57.87 | 58.38 | 57.79 | 58.09 | 26297.00 |
May 16, 2024 | 59.10 | 59.10 | 57.90 | 57.92 | 32191.00 |
May 15, 2024 | 58.08 | 59.09 | 58.08 | 58.86 | 23854.00 |
May 14, 2024 | 55.78 | 56.77 | 55.78 | 56.30 | 58226.00 |
May 13, 2024 | 56.79 | 57.49 | 56.79 | 57.42 | 14573.00 |
May 10, 2024 | 57.72 | 58.35 | 57.72 | 58.07 | 12601.00 |
May 09, 2024 | 54.80 | 60.94 | 54.80 | 58.08 | 18896.00 |
May 08, 2024 | 57.75 | 58.16 | 57.59 | 57.91 | 16287.00 |
May 07, 2024 | 57.38 | 57.58 | 57.06 | 57.36 | 27645.00 |
May 06, 2024 | 57.29 | 57.34 | 56.88 | 57.32 | 18376.00 |
May 03, 2024 | 57.64 | 57.84 | 57.33 | 57.41 | 23290.00 |
May 02, 2024 | 56.81 | 56.81 | 56.02 | 56.64 | 21529.00 |
May 01, 2024 | 55.38 | 56.08 | 54.81 | 55.13 | 16097.00 |
Apr 30, 2024 | 55.80 | 56.12 | 55.33 | 55.33 | 66412.00 |
Apr 29, 2024 | 57.35 | 57.44 | 57.16 | 57.27 | 38611.00 |
Apr 26, 2024 | 57.36 | 57.81 | 57.36 | 57.79 | 33920.00 |
Apr 25, 2024 | 55.92 | 56.62 | 55.86 | 56.50 | 22539.00 |
Apr 24, 2024 | 57.57 | 57.68 | 56.93 | 57.27 | 59385.00 |
Apr 23, 2024 | 57.69 | 58.06 | 57.57 | 57.57 | 92750.00 |
Apr 22, 2024 | 55.84 | 55.95 | 55.48 | 55.69 | 28853.00 |
Apr 19, 2024 | 55.35 | 55.41 | 54.95 | 55.15 | 49184.00 |
Apr 18, 2024 | 55.73 | 56.34 | 55.56 | 55.65 | 32374.00 |
Apr 17, 2024 | 57.37 | 57.45 | 56.97 | 57.30 | 33059.00 |
Apr 16, 2024 | 57.54 | 57.89 | 57.39 | 57.64 | 36082.00 |
Apr 15, 2024 | 58.75 | 58.81 | 57.97 | 58.05 | 27028.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
30.64
Minimum
May 31 2019
85.40
Maximum
Aug 27 2021
55.52
Average
57.44
Median
Aug 25 2022
Price Benchmarks
Roche Holding AG | 32.81 |
AC Immune SA | 3.21 |
CRISPR Therapeutics AG | 56.19 |
Addex Therapeutics Ltd | 8.79 |
NLS Pharmaceutics Ltd | 0.1533 |
Price Related Metrics
PE Ratio | 58.49 |
PS Ratio | 5.684 |
Price to Book Value | 3.723 |
Earnings Yield | 1.71% |
Market Cap | 41.89B |
Operating PE Ratio | 43.88 |
Normalized PE Ratio | 58.26 |